Tetratherix (ASX:TTX) Buyback Yield %: 0.12 (As of Jul. 07, 2026)


ASX:TTX Tetratherix Ltd ASX:TTX
15 GF Score
Price A$6.45
View Full Analysis

What is Tetratherix Buyback Yield %?

Tetratherix ASX:TTX +9.69% 15 Buyback Yield % is 0.12 as of Jul. 07, 2026. GuruFocus rates ASX:TTX with a GF Score™ of 15/100. Among 740 Biotechnology companies, Tetratherix ranks better than 89.32% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Tetratherix's current buyback yield was 0.12%.

Tetratherix Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Tetratherix's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tetratherix Buyback Yield % Chart

Tetratherix Annual Data
Trend Jun23 Jun24 Jun25
Buyback Yield %
0.00 0.00 -14.93

Tetratherix Semi-Annual Data
Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Buyback Yield % Get a 7-Day Free Trial 0.00 0.00 0.00 -14.93 0.22

ASX:TTX vs VRTX, REGN, ALNY: Buyback Yield % Comparison

For the Biotechnology subindustry, Tetratherix's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tetratherix Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tetratherix's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Tetratherix's Buyback Yield % falls into.


ASX:TTX
15GF Score
Tetratherix Ltd ASX:TTX
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tetratherix Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Tetratherix's Buyback Yield for the fiscal year that ended in Jun. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (-2.3 + 24.998) / 152.00264
=-14.93%

Tetratherix's annualized Buyback Yield for the quarter that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (-0.357 + 0) / 165.08896
=0.22%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.12 mean?
Tetratherix (ASX:TTX) has a Buyback Yield % of 0.12 as of Jul. 07, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Tetratherix and its competitors. According to the industry distribution chart, Tetratherix ranks #79 out of 740 companies in the Biotechnology industry, placing it in the top 10.7%.
Is Tetratherix's Buyback Yield % too high?
Tetratherix's current Buyback Yield % is 0.12. Based on the distribution chart, Tetratherix ranks #79 out of 740 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Tetratherix has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Tetratherix's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Tetratherix ranks #79 out of 740 companies for Buyback Yield %. This places Tetratherix in the top 11% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Tetratherix and its competitors. Tetratherix's current Buyback Yield % is 0.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tetratherix stock overvalued right now?
Tetratherix (ASX:TTX) has a current Buyback Yield % of 0.12. The current Buyback Yield % is 0.12. Tetratherix's overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Tetratherix (ASX:TTX), the current Buyback Yield % is 0.12 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tetratherix Business Description

Address 34-36 Ralph Street, Unit 29, Alexandria, Sydney, NSW, AUS, 2015
Tetratherix Ltd is a biomedical company that has developed an biomaterial platform called Tetramatrix, a proprietary fluid matrix that induces minimal foreign body reaction. The principal activities include development programs in the areas of regenerative medicine and commercialising medical device technology across multiple applications including Bone Regeneration, Tissue Spacing and Tissue Healing.
15GF Score

Get the complete analysis for ASX:TTX

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$6.45
Price